Tag: Financial aid

Without insurance, the list price for a one-month supply of the brand-name medication OFEV (nintedanib) can exceed $14,000. For those with insurance, the out-of-pocket expenses vary significantly, though manufacturer programs can help reduce costs for eligible patients to as little as $0 per month. Understanding the different financial avenues is crucial for managing the cost of this vital medication.

While the quality of epilepsy treatments has dramatically improved, the cost of newer, brand-name anti-seizure medications has also significantly increased, making cost a major concern for many patients. So, do you have to pay for epilepsy medication? The short answer is yes, in most cases, but the exact amount depends on several factors, and there are numerous programs to help reduce the financial burden.

The cost of Eylea (aflibercept) injection can pose a significant financial burden for many patients, potentially costing thousands of dollars per dose. Fortunately, financial assistance is available through various programs. This guide will walk you through **how to get Eylea for free** or with considerable financial support by leveraging manufacturer and charitable aid initiatives.

Without insurance, a single vial of Vpriv (velaglucerase alfa) has an approximate list price of nearly $1,500. As a treatment for the rare genetic disorder Gaucher disease, the annual cost can potentially exceed six figures, making the question of **how much does Vpriv cost?** a critical concern for patients and their families.

Treatment with Oxervate, the first FDA-approved eye drop for neurotrophic keratitis (NK), can carry a list price estimated at over $118,000 for a full 8-week course. This substantial cost highlights the significant financial considerations for patients needing this specialized medication.